2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 24813620 | Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study. | 2014 Nov | 1 |
| 2 | 23434730 | A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q). | 2013 Jul | 1 |